cagrisema semaglutide cagrilintide phase 3 results 2024 2025 Coadministered and in Adults with Overweight or Obesity Cagrilintide–semaglutide (CagriSema) as an add-on

Michalak, E

Unlike stimulant-based weight loss drugs, GLP-1 works with your body's existing biology rather than forcing artificial energy depletion, which is why side effects tend to be manageable and often decrease over time

If taken out of the refrigerator, it can be kept at room temperature for up to 21 days but cannot be returned to the refrigerator

If orforglipron receives approval for obesity in April 2026, it will enter a market that Morgan Stanley estimates could reach $100 billion annually by the early 2030s, potentially transforming Eli Lilly's already dominant position in the metabolic disease space

Protein intake strategies for retatrutide users Getting enough protein while on retatrutide presents a unique challenge

Vomiting is less common than nausea and typically occurs when nausea is not adequately managed